最新新闻

冠科生物任命顾延为首席执行官

中美冠科生物科技公司任命 John Gu 为首席执行官,利用他在人工智能驱动的药物研发方面的专业知识来推动生物技术创新和全球健康。

冠科生物完成与Indivumed Services战略整合

Crown Bioscience 完成 Indivumed Services 合并,在全球范围内提供增强的药物开发解决方案,并停用 Indivumed 品牌。

冠科生物德国公司再次荣获CAP ISO 15189:2022认证

冠科生物德国公司再次荣获CAP ISO 15189:2022认证

冠科生物任命顾延为首席执行官

中美冠科生物科技公司任命 John Gu 为首席执行官,利用他在人工智能驱动的药物研发方面的专业知识来推动生物技术创新和全球健康。

冠科生物完成与Indivumed Services战略整合

Crown Bioscience 完成 Indivumed Services 合并,在全球范围内提供增强的药物开发解决方案,并停用 Indivumed 品牌。

冠科生物德国公司再次荣获CAP ISO 15189:2022认证

冠科生物德国公司再次荣获CAP ISO 15189:2022认证

新闻话题

img-description

JSR Life Sciences

JSR Life Sciences is committed to the advancement of human health worldwide as a strategic partner to companies that discover, develop & deliver products to treat disease & improve quality of life

img-description

Crown Bioscience

Crown Bioscience is a contract research & translational technology company making precision medicine a reality

img-description

KBI Biopharma

KBI Biopharma is an award winning CDMO providing fully-integrated, accelerated drug development & biomanufacturing services to pharmaceutical & biotechnology companies globally

img-description

MBL

MBL is committed to being a leading manufacturer & supplier of diagnostic reagents that facilitate further advances in personalized medicine & individualization of medical care

img-description

JSR Corporation

JSR Corporation's mission is to contribute to social good by supplying materials to serve future generations & providing new value today for their customers & society

接收独家新闻

新闻工作者?或是服务于某一家媒体?
注册以申请获得独家新闻。

立即注册

Receive JSR Life Sciences news on your RSS reader.

Or subscribe through Atom URL manually